SCHEMBL16015162

SCHEMBL16015162

Cc1ccc(C(=O)N[C@@H]2CCCC[C@H]2NC(=O)C2CCCN2)cc1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.52
NPC1 O15118 1/20 0.52
CYP1A2 P05177 1/20 0.52
HPGD P15428 1/20 0.52
CYP2C19 P33261 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
SSTR3 P32745 3/20 0.51
CCR2 P41597 1/20 0.43
TAS1R3 Q7RTX0 3/20 0.43
TAS1R2 Q8TE23 3/20 0.43
TAS1R1 Q7RTX1 2/20 0.43
MLYCD O95822 1/20 0.42
USP2 O75604 1/20 0.40
HTR2C P28335 1/20 0.40
HTR2B P41595 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13964104 1.00 RAB9A (0.52) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL12348733 0.80 PRCP (0.46) HTR2CHTR2B
SCHEMBL16015169 0.80 PRCP (0.46) HTR2CHTR2B
SCHEMBL28565006 0.75 RAB9A (0.56) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL13927734 0.75 TAS1R3 (0.72) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL4175029 0.75 TAS1R3 (0.72) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL29933088 0.75 RAB9A (0.64) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL13927736 0.75 TAS1R3 (0.72) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL28322880 0.74 MEN1 (0.54) RAB9ANPC1CYP1A2HPGDCYP2C19
SCHEMBL28564491 0.74 RAB9A (0.59) RAB9ANPC1CYP1A2HPGDCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8829208-B2 Process for the preparation of darunavir and darunavir intermediates MAPI PHARMA LTD. (IL) 2014-09-09 US disclosed
US-8829208-B2 Process for the preparation of darunavir and darunavir intermediates MAPI PHARMA LTD. (IL) 2014-09-09 US disclosed